Phosphatases reverse p53-mediated cell cycle checkpoints

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 20, 2014, Pages 7172-7173

  Donehower, Lawrence A ^a  

^a Human Genome Sequencing Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 1; DUSP26 PROTEIN; PHOSPHATASE; PROTEIN P53; UNCLASSIFIED DRUG; WIP1 PROTEIN;

CANCER CELL; CELL CYCLE CHECKPOINT; DOWN REGULATION; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; NOTE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STRESS;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PHOSPHOPROTEIN PHOSPHATASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84901036363     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1405663111     Document Type: Note

References (17)

1. Lawrence MS, et al. (2013) Mutational heterogeneity in cancer and the search for new cancer-Associated genes. Nature 499(7457):214-218.
2. Shaltiel IA, et al. (2014) Distinct phosphatases antagonize the p53 response in different phases of the cell cycle. Proc Natl Acad Sci USA 111:7313-7318.
3. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358(6381):15-16.
4. Meek DW, Anderson CW (2009) Posttranslational modification of p53: Cooperative integrators of function. Cold Spring Harb Perspect Biol 1(6):a000950.
5. Lu X, Nannenga B, Donehower LA (2005) PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev 19(10):1162-1174.
6. Lindqvist A, et al. (2009) Wip1 confers G2 checkpoint recovery competence by counteracting p53-dependent transcriptional repression. EMBO J 28(20):3196-3206.
7. Fiscella M, et al. (1997) Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA 94(12):6048-6053.
8. Bulavin DV, et al. (2002) Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat Genet 31(2):210-215.
9. Shang X, et al. (2010) Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma. Oncogene 29(35): 4938-4946.
10. Lu Z, Wan G, Guo H, Zhang X, Lu X (2013) Protein phosphatase 1 inhibits p53 signaling by dephosphorylating and stabilizing Mdmx. Cell Signal 25(4):796-804.
11. Hsu LC, Huang X, Seasholtz S, Potter DM, Gollin SM (2006) Gene amplification and overexpression of protein phosphatase 1alpha in oral squamous cell carcinoma cell lines. Oncogene 25(40):5517-5526.
12. Lee DH, et al. (2012) Phosphoproteomic analysis reveals that PP4 dephosphorylates KAP-1 impacting the DNA damage response. EMBO J 31(10):2403-2415.
13. Li X, et al. (2007) Role for KAP1 serine 824 phosphorylation and sumoylation/desumoylation switch in regulating KAP1-mediated transcriptional repression. J Biol Chem 282(50):36177-36189.
14. Wang B, et al. (2008) Protein phosphatase PP4 is overexpressed in human breast and lung tumors. Cell Res 18(9):974-977.
15. Weng S, et al. (2012) Overexpression of protein phosphatase 4 correlates with poor prognosis in patients with stage II pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev 21(8):1336-1343.
16. Rayter S, et al. (2008) A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D. Oncogene 27(8):1036-1044.
17. Gilmartin AG, et al. (2014) Allosteric Wip1 phosphatase inhibition through flap-subdomain interaction. Nat Chem Biol 10(3): 181-187.